Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05190874 · ClinicalTrials.gov registry record
Grappler Interference Screw Post-Market Collection of Patient Reported Outcome Measures
A clinical trial, sponsored by Paragon 28.
- Completed
- Registry status
- 19
- Enrollment target
NCT05190874: Completed study, sponsored by Paragon 28.
NCT05190874 is a clinical trial that has completed, run by Paragon 28. The registered enrollment target is 19 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05190874 has completed, sponsored by Paragon 28.
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
Study Summary
Ambispective, multi-surgeon, single site, consecutive case series to determine the safety, performance, and benefits of the Grappler(R) Interference Screw.
Primary Outcome
Device performance and benefits as related to Foot and Ankle Mobility Measure Activities of Daily Living (0-84) and sports (0-32) subscales. The higher the score, the higher the level of function, with 100% representing no dysfunction.
Interventions
- DEVICE Grappler Interference Screw System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2022-01-14 |
| Est. Completion | 2022-04-06 |
What the finished NCT05190874 record still lists
NCT05190874 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 19 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Grappler Interference Screw System is the first listed.
NCT05190874 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05190874 about?
NCT05190874 is a clinical study titled "Grappler Interference Screw Post-Market Collection of Patient Reported Outcome Measures". Ambispective, multi-surgeon, single site, consecutive case series to determine the safety, performance, and benefits of the Grappler(R) Interference Screw.
What is the current status of trial NCT05190874?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2022-01-14. Estimated completion is 2022-04-06.
What interventions are being tested in trial NCT05190874?
The interventions under investigation include: Grappler Interference Screw System (DEVICE).
Who is sponsoring clinical trial NCT05190874?
This trial is sponsored by Paragon 28, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI